Your browser doesn't support javascript.
loading
Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial.
Diaz, Ricardo Sobhie; Shytaj, Iart Luca; Giron, Leila B; Obermaier, Benedikt; Della Libera, Ermelindo; Galinskas, Juliana; Dias, Danilo; Hunter, James; Janini, Mario; Gosuen, Gisele; Ferreira, Paulo Abrão; Sucupira, Maria Cecilia; Maricato, Juliana; Fackler, Oliver; Lusic, Marina; Savarino, Andrea.
Afiliação
  • Diaz RS; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Shytaj IL; Heidelberg University Hospital, Department of Infectious Diseases, Heidelberg 69120, Germany; German Center for Infection Research, Heidelberg 69120, Germany.
  • Giron LB; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil; The Wistar Institute, Philadelphia, PA, USA.
  • Obermaier B; Heidelberg University Hospital, Department of Infectious Diseases, Heidelberg 69120, Germany; German Center for Infection Research, Heidelberg 69120, Germany.
  • Della Libera E; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Galinskas J; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Dias D; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Hunter J; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Janini M; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Gosuen G; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Ferreira PA; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Sucupira MC; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Maricato J; Federal University of Sao Paulo, Infectious Diseases Department, São Paulo, 04021-001, Brazil.
  • Fackler O; Heidelberg University Hospital, Department of Infectious Diseases, Heidelberg 69120, Germany; German Center for Infection Research, Heidelberg 69120, Germany.
  • Lusic M; Heidelberg University Hospital, Department of Infectious Diseases, Heidelberg 69120, Germany; German Center for Infection Research, Heidelberg 69120, Germany.
  • Savarino A; Department of Infectious Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, I-00161 Rome, Italy. Electronic address: andrea.savarino@iss.it.
Int J Antimicrob Agents ; 54(5): 592-600, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31394172
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Auranofina / HIV-1 / Provírus / Latência Viral / Antirreumáticos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Antimicrob Agents Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Auranofina / HIV-1 / Provírus / Latência Viral / Antirreumáticos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Antimicrob Agents Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil